Volume 27, Number 4, December 2025
Editoral in Hungarian
Gábor Faludi
The National Survey on Addiction Problems in Hungary 2023 (NSAPH): Methodology and sample description
Borbála Paksi, Zsolt Demetrovics, Anna Péterfi, Andrea Eisinger, Katalin Felvinczi
Abstract
Keywords: addiction problems, representative population survey, methodology, smoking, alcohol consumption, psychoactive substance use, behavioral addictions
Results of the evaluation of cognitive functions in acute haemorrhagic stroke
Réka Majer, Máté Héja, Zsuzsa Bagoly, László Oláh, László Csiba, Klára Fekete
Abstract
Keywords: cognitive function, neurocognitive dysfunction, poststroke cognitive impairment, cognitive evaluation
Developing a model of Students' Academic Burnout Based on academic Support: The Intermediating Role of Academic Engagement
Vahideh Sadah Vahedi, Mohammad Tahan
Abstract
(Neuropsychopharmacol Hung 2025; 27(4): 270–281)
Keywords: Academic Involvement, Academic Support, Academic Burnout, Structural Equation Method
Abstract
(Neuropsychopharmacol Hung 2025; 27(4): 282–295)
Keywords: bipolar disorder, bipolar spectrum disorder, biomarker, psychodiagnostics
A neutrophil-to-lymphocyte ratio higher than 3 may identify inflammation during clozapine titrations: A re-analysis of five published cases of myocarditis
Jose De Leon, Robert O. Cotes, David R. Goldsmith, Charles Shelton, Betsy MacCollum
Abstract
17. CRP and NLR finally normalized on day 35. Skin abscesses led to abnormal CRP and NLR values. On day 148, 12.5 mg of clozapine was restarted leading to a skin rash the next day. On day 155, this dose was stopped. Case 4 had two normal NLRs before myocarditis, but on day 16, clozapine was stopped (abnormal CRP, 15.8 μg/dL, ≤0.5 and abnormal NLR=4.4). Case 5 had BEN. NLR was normal on day 7, but became abnormal (NLR=1.9) on day 11 on 250 mg/day. He died five days later. Conclusions: An abnormal NLR during titration may suggest clozapine-induced inflammation and/or infection.
(Neuropsychopharmacol Hung 2025; 27(4): 296–311)
Keywords: clozapine/administration and dosage, clozapine/adverse effects, clozapine/ blood, clozapine/metabolism, clozapine/pharmacokinetics, drug interaction, drug moni-toring, inflammation, myocarditis/chemically induced, myocarditis/etiology, myocarditis/ prevention and control, schizophrenia


